Evidence map›Paper›PMID 23505424›Full record

ArticlePloS one2013

Cellular effects of curcumin on Plasmodium falciparum include disruption of microtubules.

Rimi Chakrabarti, Parkash S Rawat, Brian M Cooke, Ross L Coppel, Swati Patankar

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Antimalarial efficacy ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2024
    Article
  2. Microbiology spectrum · 2024
    Article
  3. Curcumin ameliorates chronicIranian journal of basic medical sciences · 2023
    Article
  4. Antiproliferative Effects of Curcumin Different Types of Breast Cancer.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
  5. Piperine Enhances the Antimalarial Activity of Curcumin inEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  6. Effects of Curcumin and Its Analogues on Infectious Diseases.Advances in experimental medicine and biology · 2021
    Review
  7. Article
  8. Review
  9. Cytotoxic and Anti-Plasmodial Activities ofMolecules (Basel, Switzerland) · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rimi ChakrabartiDepartment of Biosciences and Bioengineering, Indian Institute of Technology Bombay (IITB), Mumbai, India.
Parkash S Rawat
Brian M Cooke
Ross L Coppel
Swati Patankar

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin has been widely investigated for its myriad cellular effects resulting in reduced proliferation of various eukaryotic cells including cancer cells and the human malaria parasite Plasmodium falciparum. Studies with human cancer cell lines HT-29, Caco-2, and MCF-7 suggest that curcumin can bind to tubulin and induce alterations in microtubule structure. Based on this finding, we investigated whether curcumin has any effect on P. falciparum microtubules, considering that mammalian and parasite tubulin are 83% identical. IC50 of curcumin was found to be 5 µM as compared to 20 µM reported before. Immunofluorescence images of parasites treated with 5 or 20 µM curcumin showed a concentration-dependent effect on parasite microtubules resulting in diffuse staining contrasting with the discrete hemispindles and subpellicular microtubules observed in untreated parasites. The effect on P. falciparum microtubules was evident only in the second cycle for both concentrations tested. This diffuse pattern of tubulin fluorescence in curcumin treated parasites was similar to the effect of a microtubule destabilizing drug vinblastine on P. falciparum. Molecular docking predicted the binding site of curcumin at the interface of alpha and beta tubulin, similar to another destabilizing drug colchicine. Data from predicted drug binding is supported by results from drug combination assays showing antagonistic interactions between curcumin and colchicine, sharing a similar binding site, and additive/synergistic interactions of curcumin with paclitaxel and vinblastine, having different binding sites. This evidence suggests that cellular effects of curcumin are at least, in part, due to its perturbing effect on P. falciparum microtubules. The action of curcumin, both direct and indirect, on P. falciparum microtubules is discussed.

Indexed as

Binding SitesColchicineCurcuminDose-Response Relationship, DrugDrug SynergismErythrocytesHemolysisHumansMicrotubulesMolecular Docking SimulationPaclitaxelPlasmodium falciparumProtein BindingProtein ConformationProtein MultimerizationTubulinColchicineCurcuminPaclitaxelTubulinTubulin ModulatorsVinblastine

Identifiers

PMID23505424
PMCPMC3591428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.